PD-0332991, 5-FU, and Oxaliplatin for Advanced Solid Tumor Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trials Related to Oxaliplatin
Related studies linked through entity extraction aliases.
Intrahepatic Chemotherapy to Patients With Non-resectable Liver Metastases From Solid Tumor
- Status
- UNKNOWN
- Phase
- PHASE2
Phase 2 Study of Erlotinib, Gemcitabine and Oxaliplatin Combination Chemotherapy to Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Trastuzumab, Capecitabine y Oxaliplatine as Treatment Gastric Cancer Metastatic (HER2)Positive
- Status
- COMPLETED
- Phase
- PHASE2
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment
- Status
- UNKNOWN
- Phase
- PHASE2
Phase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
- Status
- COMPLETED
- Phase
- PHASE2
A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Sequential HIPEC of Oxaliplatin and Paclitaxel for Gastric Cancer Patients With Peritoneum Metastasis
- Status
- UNKNOWN
- Phase
- PHASE2
Study of GEMOX(Gemcitabine/Oxaliplatin) Versus XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
Study of LV5FU2 Versus FOLFOX for Curatively-resected, Node-positive Esophageal Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE2
An Observational Study of Adjuvant Treatment With Capecitabine (Xeloda) in Combination With Oxaliplatin in Participants With Stage III Colon Cancer
- Status
- COMPLETED
- Phase
- N/A
FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study Evaluating the Efficacy and Safety of MEGF0444A Dosed to Progression in Combination With Bevacizumab and mFOLFOX-6 in Participants With Previously Untreated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2